Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gifford Shin Nippon PLC Regulatory News (BGS)

Share Price Information for Baillie Gifford Shin Nippon PLC (BGS)

Share Price is delayed by 15 minutes
Get Live Data
159.60    2.80 (1.79%)
Bid:
158.00
Ask:
159.80
Spread: 1.80 (1.139%)
Market Cap: £318.76m
BGS Live PriceLast checked at - London Stock Exchange

Intraday Baillie Gifford Shin Nippon PLC Share Chart

Kepler Trust Intelligence: New Research

29 Apr 2024 07:00

RNS Number : 2146M
Baillie Gifford Shin Nippon PLC
29 April 2024
 

Baillie Gifford Shin Nippon: New Research

29/04/2024

BGS's portfolio is seeing strong sales growth but looks cheaper and cheaper…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAPLKAAFLEEA
Date   Source Headline
30th Sep 20254:48 pmRNSTransaction in Own Shares
30th Sep 202511:35 amRNSNet Asset Value(s)
29th Sep 202511:42 amRNSNet Asset Value(s)
26th Sep 20251:20 pmRNSNet Asset Value(s)
25th Sep 20254:50 pmRNSTransaction in Own Shares
25th Sep 202511:29 amRNSNet Asset Value(s)
24th Sep 202511:40 amRNSNet Asset Value(s)
23rd Sep 202512:02 pmRNSNet Asset Value(s)
22nd Sep 202512:23 pmRNSNet Asset Value(s)
19th Sep 202512:01 pmRNSNet Asset Value(s)
18th Sep 202512:18 pmRNSNet Asset Value(s)
17th Sep 202512:27 pmRNSNet Asset Value(s)
17th Sep 20259:44 amRNSHalf-year Report
16th Sep 20254:52 pmRNSTransaction in Own Shares
16th Sep 202511:41 amRNSNet Asset Value(s)
15th Sep 20254:51 pmRNSTransaction in Own Shares
15th Sep 202511:59 amRNSNet Asset Value(s)
12th Sep 20255:00 pmRNSTransaction in Own Shares
12th Sep 202512:16 pmRNSNet Asset Value(s)
11th Sep 202511:37 amRNSNet Asset Value(s)
10th Sep 202511:58 amRNSNet Asset Value(s)
9th Sep 20254:47 pmRNSTransaction in Own Shares
9th Sep 202512:19 pmRNSNet Asset Value(s)
8th Sep 20254:55 pmRNSTransaction in Own Shares
8th Sep 202512:41 pmRNSNet Asset Value(s)
5th Sep 20254:48 pmRNSTransaction in Own Shares
5th Sep 202512:16 pmRNSNet Asset Value(s)
5th Sep 20257:00 amRNSHalf-year Report
4th Sep 202512:14 pmRNSNet Asset Value(s)
3rd Sep 202512:43 pmRNSNet Asset Value(s)
2nd Sep 20254:52 pmRNSTransaction in Own Shares
2nd Sep 202512:27 pmRNSNet Asset Value(s)
1st Sep 20251:02 pmRNSNet Asset Value(s)
1st Sep 202511:56 amRNSTotal Voting Rights
29th Aug 20254:54 pmRNSTransaction in Own Shares
29th Aug 202512:19 pmRNSNet Asset Value(s)
28th Aug 202511:57 amRNSNet Asset Value(s)
27th Aug 202511:40 amRNSNet Asset Value(s)
26th Aug 20255:01 pmRNSTransaction in Own Shares
26th Aug 202512:07 pmRNSNet Asset Value(s)
26th Aug 20259:36 amRNSNet Asset Value(s)
26th Aug 20257:00 amRNSCancellation of share premium account
22nd Aug 202511:48 amRNSNet Asset Value(s)
21st Aug 202512:03 pmRNSNet Asset Value(s)
20th Aug 20254:51 pmRNSTransaction in Own Shares
20th Aug 202511:59 amRNSNet Asset Value(s)
19th Aug 202511:39 amRNSNet Asset Value(s)
18th Aug 202511:52 amRNSNet Asset Value(s)
15th Aug 202511:02 amRNSNet Asset Value(s)
14th Aug 202511:40 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.